KDOQI (Kidney Disease Outcomes Quality Initiative)

NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism
History of KDOQI



KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease


TABLES

Table 1.   Stages of Chronic Kidney Disease

Table 2.  Major Features of Abnormalities in Mineral Metabolism in Kidney Failure

Table 3.  Factors Affecting the Level of Serum Phosphorus in CKD

Table 4.  Biological Consequences of Vitamin D Deficiency

Table 5.  Possible Reasons for Variations in Bone Disease Among Patients with Chronic Kidney Disease

Table 6.  Factors That May Predispose to Soft-Tissue Calcification in Stages 4 and 5 CKD

Table 7.  Steps Used to Develop the Bone Disease Guidelines

Table 8.  Summary of Article Retrievals

Table 9.  Evidence Base for Evidence Reports

Table 10. Rating of Methodological Quality

Table 11. Rating of Applicability

Table 12. Example of a Study Quality Overview Table

Table 13. Grading Rationale Statements

Table 14. Frequency of Measurement of PTH and Calcium/Phosphorus by Stage of CKD

Table 15. Target Range of Intact Plasma PTH by Stage of CKD

Table 16. Factors Prevalent in CKD Patients Which May Influence the Type of Osteodystrophy Lesion

Table 17. Non–CKD-Related Factor Which May Affect Bone Metabolism in CKD Patients

Table 18. Pathologies Identified by Bone Biopsy Measures

Table 19. Side Effects Associated with a Phosphorus-Restricted Diet and Their Rate of Occurrence

Table 20. Phosphorus Content of Protein-Containing Foods

Table 21. Steps To Calculate the Initial Binder Prescription

Table 22. Phosphorus-Binding Compounds

Table 23. Adequate and Upper Intake Levels of Calcium for Healthy People by Age

Table 24. Calcium Content of Common Calcium-Based Binders

Table 25. Factorial Analysis for Determining Calcium Requirements in Adults Aged 19-30 Years

Table 26. Recommended Supplementation for Vitamin D Deficiency/Insufficiency in Patients with CKD Stages 3 and 4

Table 27. Serum Levels of PTH, Calcium and Phosphate Required for Initiation of Oral Vitamin D Sterol Therapy, and Recommended Initial Doses in Patients with Stages 3 and 4 CKD

Table 28. Recommended Initial Dosing for Vitamin D Sterols by Serum Levels of Intact PTH, Calcium, Phosphorus, and Ca-P Product

Table 29. Effect of Dialysis Membranes on the Development of Clinical or Radiographic Symptoms of β2-Microglobulin Amyloidosis

Table 30. Summary of the Results of the Effect of Different Dialysis Membranes on β2-Microglobulin Serum Levels

Table 31. Aluminum-Related Disorders: Features, Causes and Considerations for Therapy

Table 32. Frequency for Measurement of Serum Levels of Total CO2

Table 33. Frequency of Measurement of Calcium, Phosphorus, PTH and Total CO2 after Kidney Transplantation

Table 34. Commercially Available Preparations for Phosphate Supplementation

 


© 2003 National Kidney Foundation, Inc.